House David Duane bought ARMP
February 5, 2025 · Form 4 insider transaction
House David Duane bought 25,000 shares of Armata Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
25,000
Price
$0.00
Total value
N/A
InsiderHouse David Duane
Role—
SecurityStock Options (Right to Buy)
Transaction codeA: Grant or award
Transaction dateFebruary 5, 2025
Filing dateFebruary 7, 2025
Shares owned after25,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Twenty-five percent (25%) of the Stock Options shall vest on February 5th of each of 2026, 2027, 2028 and 2029, in each case subject to continuous service through the applicable vesting date.